AAAAAA

   
Results: 1-25 | 26-47
Results: 1-25/47
Re: Population-based study of BRCA1 and BRCA2 mutations in 1035 unselectedFinnish breast cancer patients - Response
Authors: Vahteristo, P Syrjakoski, K Eerola, H Kainu, T Holli, K Blomqvist, C Kallioniemi, OP Nevanlinna, H
Citation: P. Vahteristo et al., Re: Population-based study of BRCA1 and BRCA2 mutations in 1035 unselectedFinnish breast cancer patients - Response, J NAT CANC, 93(2), 2001, pp. 153-154
Association of E-cadherin germ-line alterations with prostate cancer
Authors: Ikonen, T Matikainen, M Mononen, N Hyytinen, ER Helin, HJ Tommola, S Tammela, TLJ Pukkala, E Schleutker, J Kallioniemi, OP Koivisto, PA
Citation: T. Ikonen et al., Association of E-cadherin germ-line alterations with prostate cancer, CLIN CANC R, 7(11), 2001, pp. 3465-3471
Tissue microarrays: What will they bring to molecular and anatomic pathology?
Authors: Moch, H Kononen, J Kallioniemi, OP Sauter, G
Citation: H. Moch et al., Tissue microarrays: What will they bring to molecular and anatomic pathology?, ADV ANAT PA, 8(1), 2001, pp. 14-20
From chromosomal alterations to target genes for therapy: integrating cytogenetic and functional genomic views of the breast cancer genome
Authors: Monni, O Hyman, E Mousses, S Barlund, M Kallioniemi, A Kallioniemi, OP
Citation: O. Monni et al., From chromosomal alterations to target genes for therapy: integrating cytogenetic and functional genomic views of the breast cancer genome, SEM CANC B, 11(5), 2001, pp. 395-401
Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families
Authors: Barkardottir, RB Sarantaus, L Arason, A Vehmanen, P Bendahl, PO Kainu, T Syrjakoski, K Krahe, R Huusko, P Pyrhonen, S Holli, K Kallioniemi, OP Egilsson, V Kere, J Nevanlinna, H
Citation: Rb. Barkardottir et al., Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families, EUR J HUM G, 9(10), 2001, pp. 773-779
Tissue microarray technology for high-throughput molecular profiling of cancer
Authors: Kallioniemi, OP Wagner, U Kononen, J Sauter, G
Citation: Op. Kallioniemi et al., Tissue microarray technology for high-throughput molecular profiling of cancer, HUM MOL GEN, 10(7), 2001, pp. 657-662
Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in Finland
Authors: Matikainen, MP Pukkala, E Schleutker, J Tammela, TLJ Koivisto, P Sankila, R Kallioniemi, OP
Citation: Mp. Matikainen et al., Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in Finland, CANC CAUSE, 12(3), 2001, pp. 223-230
Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas - a possible mechanism for altering the nm23-H1 activity
Authors: Forus, A D'Angelo, A Henriksen, J Merla, G Maelandsmo, GM Florenes, VA Olivieri, S Bjerkehagen, B Meza-Zepeda, LA Blanco, FD Muller, C Sanvito, F Kononen, J Nesland, JM Fodstad, O Reymond, A Kallioniemi, OP Arrigoni, G Ballabio, A Myklebost, O Zollo, M
Citation: A. Forus et al., Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas - a possible mechanism for altering the nm23-H1 activity, ONCOGENE, 20(47), 2001, pp. 6881-6890
Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling
Authors: Mousses, S Wagner, U Chen, YD Kim, JW Bubendorf, L Bittner, M Pretlow, T Elkahloun, AG Trepel, JB Kallioniemi, OP
Citation: S. Mousses et al., Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling, ONCOGENE, 20(46), 2001, pp. 6718-6723
Biochip technologies in cancer research
Authors: Kallioniemi, OP
Citation: Op. Kallioniemi, Biochip technologies in cancer research, ANN MED, 33(2), 2001, pp. 142-147
ANX7 as a bio-marker in prostate and breast cancer progression
Authors: Srivastava, M Bubendorf, L Nolan, L Glasman, M Leighton, X Miller, G Fehrle, W Raffeld, M Eidelman, O Kallioniemi, OP Srivastava, S Pollard, HB
Citation: M. Srivastava et al., ANX7 as a bio-marker in prostate and breast cancer progression, DIS MARKER, 17(2), 2001, pp. 115-120
Genetic changes in familial prostate cancer by comparative genomic hybridization
Authors: Rokman, A Koivisto, PA Matikainen, MP Kuukasjarvi, T Poutiainen, M Helin, HJ Karhu, R Kallioniemi, OP Schleutker, J
Citation: A. Rokman et al., Genetic changes in familial prostate cancer by comparative genomic hybridization, PROSTATE, 46(3), 2001, pp. 233-239
Gene-expression profiles in hereditary breast cancer.
Authors: Hedenfalk, I Duggan, D Chen, YD Radmacher, M Bittner, M Simon, R Meltzer, P Gusterson, B Esteller, M Kallioniemi, OP Wilfond, B Borg, A Trent, J
Citation: I. Hedenfalk et al., Gene-expression profiles in hereditary breast cancer., N ENG J MED, 344(8), 2001, pp. 539-548
ANX7, a candidate tumor suppressor gene for prostate cancer
Authors: Srivastava, M Bubendorf, L Srikantan, V Fossom, L Nolan, L Glasman, M Leighton, X Fehrle, W Pittaluga, S Raffeld, M Koivisto, P Willi, N Gasser, TC Kononen, J Sauter, G Kallioniemi, OP Srivastava, S Pollard, HB
Citation: M. Srivastava et al., ANX7, a candidate tumor suppressor gene for prostate cancer, P NAS US, 98(8), 2001, pp. 4575-4580
Tissue microarrays (TMAs) for high-throughput molecular pathology research
Authors: Nocito, A Kononen, J Kallioniemi, OP Sauter, G
Citation: A. Nocito et al., Tissue microarrays (TMAs) for high-throughput molecular pathology research, INT J CANC, 94(1), 2001, pp. 1-5
ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer
Authors: Rokman, A Ikonen, T Mononen, N Autio, V Matikainen, MP Koivisto, PA Tammela, TLJ Kallioniemi, OP Schleutker, J
Citation: A. Rokman et al., ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer, CANCER RES, 61(16), 2001, pp. 6038-6041
A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland
Authors: Mononen, N Ikonen, T Syrjakoski, K Matikainen, M Schleutker, J Tammela, TLJ Koivisto, PA Kallioniemi, OP
Citation: N. Mononen et al., A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland, BR J CANC, 84(10), 2001, pp. 1344-1347
Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites
Authors: Rapakko, K Allinen, M Syrjakoski, K Vahteristo, P Huusko, P Vahakangas, K Eerola, H Kainu, T Kallioniemi, OP Nevanlinna, H Winqvist, R
Citation: K. Rapakko et al., Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites, BR J CANC, 84(1), 2001, pp. 116-119
Tissue microarrays for rapid linking of molecular changes to clinical endpoints
Authors: Torhorst, J Bucher, C Kononen, J Haas, P Zuber, M Kochli, OR Mross, F Dieterich, H Moch, H Mihatsch, M Kallioniemi, OP Sauter, G
Citation: J. Torhorst et al., Tissue microarrays for rapid linking of molecular changes to clinical endpoints, AM J PATH, 159(6), 2001, pp. 2249-2256
Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients
Authors: Syrjakoski, K Vahteristo, P Eerola, H Tamminen, A Kivinummi, K Sarantaus, L Holli, K Blomqvist, C Kallioniemi, OP Kainu, T Nevanlinna, H
Citation: K. Syrjakoski et al., Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients, J NAT CANC, 92(18), 2000, pp. 1529-1531
Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis
Authors: Barlund, M Forozan, F Kononen, J Bubendorf, L Chen, YD Bittner, ML Torhorst, J Haas, P Bucher, C Sauter, G Kallioniemi, OP Kallioniemi, A
Citation: M. Barlund et al., Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis, J NAT CANC, 92(15), 2000, pp. 1252-1259
A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: Frequent HPCX linkage in families with late-onset disease
Authors: Schleutker, J Matikainen, M Smith, J Koivisto, P Baffoe-Bonnie, A Kainu, T Gillanders, E Sankila, R Pukkala, E Carpten, J Stephan, D Tammela, T Brownstein, M Bailey-Wilson, J Trent, J Kallioniemi, OP
Citation: J. Schleutker et al., A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: Frequent HPCX linkage in families with late-onset disease, CLIN CANC R, 6(12), 2000, pp. 4810-4815
Distance-based reconstruction of tree models for oncogenesis
Authors: Desper, R Jiang, F Kallioniemi, OP Moch, H Papadimitriou, CH Schaffer, AA
Citation: R. Desper et al., Distance-based reconstruction of tree models for oncogenesis, J COMPUT BI, 7(6), 2000, pp. 789-803
Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland
Authors: Sarantaus, L Huusko, P Eerola, H Launonen, V Vehmanen, P Rapakko, K Gillanders, E Syrjakoski, K Kainu, T Vahteristo, P Krahe, R Paakkonen, K Hartikainen, J Blomqvist, C Lopponen, T Holli, K Ryynanen, M Butzow, R Borg, A Arver, BW Holmberg, E Mannermaa, A Kere, J Kallioniemi, OP Winqvist, R Nevanlinna, H
Citation: L. Sarantaus et al., Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland, EUR J HUM G, 8(10), 2000, pp. 757-763
Novel findings in gene expression detected in human osteosarcoma by cDNA microarray
Authors: Wolf, M El-Rifai, W Tarkkanen, M Kononen, J Serra, M Eriksen, EF Elomaa, I Kallioniemi, A Kallioniemi, OP Knuutila, S
Citation: M. Wolf et al., Novel findings in gene expression detected in human osteosarcoma by cDNA microarray, CANC GENET, 123(2), 2000, pp. 128-132
Risultati: 1-25 | 26-47